Optimized alveolar epithelial cell model for chronic Pseudomonas aeruginosa and Staphylococcus aureus coinfections

Area of Science:

• Microbiology
• Infectious Diseases
• Biofilm Research

Background:

• Pseudomonas aeruginosa is a key pathogen in chronic respiratory infections, often forming biofilms that complicate in vitro modeling and treatment.
• The co-occurrence of P. aeruginosa and Staphylococcus aureus is common in cystic fibrosis patients.
• Existing in vitro models struggle with P. aeruginosa's rapid toxin secretion, limiting study duration.

Purpose of the Study:

• To develop a reliable and extended in vitro model for studying chronic Pseudomonas aeruginosa infections.
• To investigate host-pathogen interactions involving P. aeruginosa and its relationship with Staphylococcus aureus.
• To evaluate the efficacy of ciprofloxacin treatment against P. aeruginosa in the developed model.

Main Methods:

• Optimized A549 cell culture conditions using bovine serum albumin (BSA) and extracellular matrix proteins.
• Established P. aeruginosa biofilms within the enhanced in vitro model.
• Studied host-pathogen interactions and bacterial co-colonization dynamics.
• Assessed ciprofloxacin's impact on bacterial susceptibility and strain differences.

Main Results:

• Enhanced A549 cell viability for up to 30 hours post-infection, extending study capabilities.
• Successful development of P. aeruginosa biofilms and exploration of host-pathogen interactions.
• Insights into the P. aeruginosa and Staphylococcus aureus relationship within the model.
• Observed variations in ciprofloxacin susceptibility among different bacterial strains.

Conclusions:

• The optimized in vitro model provides a robust platform for studying long-term P. aeruginosa infections and co-infections.
• The model facilitates deeper understanding of host-pathogen dynamics and antibiotic responses.
• Findings highlight the importance of considering bacterial strain variability in treatment strategies.